Faculty of Health Sciences

Bristol part of €20.8 million study to drive drug discovery for atopic dermatitis and psoriasis

11 April 2019

The lives of patients affected by atopic dermatitis and psoriasis could be improved thanks to the start of an EU-funded research project BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis). The five-year project will address key unmet needs in treating these common inflammatory skin conditions by analysing data from more than 50 000 patients to improve disease understanding, patient care and future therapies.

Discover the best of Bristol with free lecture series

16 February 2015

The most inspiring lecturers at the University of Bristol, as voted by students, will be sharing their wisdom with the public in a series of free lunchtime and evening lectures.

Free online resource to be developed for evidence-based veterinary medicine

28 April 2015

Academics from the University of Bristol’s School of Veterinary Sciences have been awarded a grant from RCVS Knowledge to create a free online teaching and learning resource for evidence-based veterinary medicine (EBVM).

Largest review of clinical trials to date finds no increased risk of suicide in patients using Champix

12 March 2015

Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are published online in the British Medical Journal [BMJ] today [12 Mar]. The study was carried out by researchers at the University of Bristol.

Could technology transform GP consultations?

20 October 2014

The way we interact with our GPs could be transformed thanks to a new £458,000 project exploring whether consultations could viably be conducted via email, text message, telephone or via the internet.

Hepatitis C could be prevented worldwide by reducing transmission in people who inject drugs

9 April 2019

Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43 per cent globally, according to a study by researchers at the University of Bristol published in the Lancet Gastroenterology and Hepatology today [Tuesday 9 April 2019].

£1.1 million project to develop new biodegradable stents

9 April 2019

A £1.1 million project to develop biodegradable stents for patients with severe vascular disease, which affects around one million people in the UK, has started thanks to Innovate UK funding. The unique project, a collaboration between the UK-based medical device company Arterius and the Translational Biomedical Research Centre (TBRC) at the University of Bristol, will develop a new type of bioresorbable stent that prevents the complications associated with metal stents.

Seeing the same doctor could affect time to cancer diagnosis

27 April 2015

Whether or not patients see the same GP could affect how quickly bowel and lung cancers are diagnosed, according to a Cancer Research UK study led by University of Bristol researchers published in the British Journal of General Practice today.

GPs and pharmacists don't have time to involve patients in medication reviews

12 February 2019

GPs and pharmacists struggle to find the time to involve patients in medication reviews, despite National Institute for Health and Care Excellence (NICE) guidance advising them to do so, according to a study by researchers at the University of Bristol's Centre for Academic Primary Care.

New website aims to improve understanding of chronic kidney disease

12 March 2015

A new website is launched today that will help bridge the communication gap between healthcare professionals and patients diagnosed with mild chronic kidney disease (CKD) after research revealed a disparity between what GP’s explain and what patients understand about the condition. The resource has been developed by University of Bristol academics.